Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOKYO.L Regulatory News (OKYO)

  • There is currently no data for OKYO

Approval of Ferrum Acquisition Passed

6 Jan 2012 13:47

RNS Number : 1509V
West African Minerals Corporation
06 January 2012
 



For immediate release: 6 January 2012

 

West African Minerals Corporation

(the "Company")

 

Result of Meeting of Shareholders

Approval of Acquisition of Ferrum Resources Limited

 

The Company is pleased to announce that at its Meeting of Shareholders held earlier today, the resolution to approve the acquisition of the entire issued and to be issued shares of Ferrum Resources Limited not already owned by the Company was duly passed. The issue of the Consideration Shares and the Placing Shares is now conditional only on admission of the Enlarged Share Capital to trading on AIM.

 

Application has been made to the London Stock Exchange for the Existing Ordinary Shares to be re-admitted and the Consideration Shares and the Placing Shares to be admitted to trading on AIM and it is expected that Admission will become effective and dealings in the Enlarged Share Capital will commence on 9 January 2012. On Admission, the Enlarged Share Capital will consist of 187,852,392 ordinary shares of no par value in the Company.

 

Expressions used in this announcement shall bear the same meanings as defined in the Company's admission document dated 20 December 2011. An electronic version of the Admission Document is available on the Company's website, www.westafricanminerals.com.

 

-- Ends --

 

Contact details

 

West African Minerals

Corporation

Religare Capital Markets (UK) Limited

Evolution Securities Limited

Beaumont Cornish Limited

GTH

Communications

Denham Eke

 

Peter Trevelyan-Clark

Emily Staples

Neil Elliott

Matt Tyler

Roland Cornish

Toby Hall

Suzanne Johnson Walsh

+44 (0)1624 639396

+44 (0)20 7444 0800

+44 (0)20 7071 4300

+44 (0)20 7628 3396

+44 (0)20 3103 3902

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRDMGGMFVKGZZM
Date   Source Headline
19th May 20238:00 amRNSADS Program collapse
15th May 20237:00 amRNSChange of Record Time and Last Day of Dealings
11th May 202312:00 pmRNSWebull Corporate Communications Service Platform
11th May 20237:00 amRNSChange of Delisting Date to 22 May 2023
3rd May 20231:00 pmRNSResult of Meeting
3rd May 20237:00 amRNSPresentation on OK-101 at ASCRS
2nd May 20237:00 amRNSFirst-Patient First-Visit for Phase 2 Trial
25th Apr 20237:00 amRNSActivation of First Clinical Trial Site in the U.S
5th Apr 20237:00 amRNSNOTICE OF GENERAL MEETING AND CIRCULAR PUBLICATION
4th Apr 20237:00 amRNSNotice Of Intention To Delist From The LSE
30th Mar 20237:00 amRNSDirector Acquires Shares
29th Mar 20237:00 amRNSDirector acquires shares
24th Mar 20237:00 amRNSDirector/PDMR Shareholding
16th Mar 20237:01 amRNSListing of Trial on the ClinicalTrials.gov Website
16th Mar 20237:00 amRNSClosing of Global Private Placement
15th Mar 20237:01 amRNSDirector/PDMR Dealings
14th Mar 20237:00 amRNSIssue of Equity
13th Mar 20233:16 pmRNSCEO Interview
6th Mar 20232:00 pmRNSPrice Monitoring Extension
28th Feb 20237:00 amRNSCustom Clearance of GMP Packaged OK-101 Drug
23rd Feb 20237:00 amRNSAppointment to Scientific Advisory Board
21st Feb 20237:00 amRNSCorporate Presentation
20th Feb 20234:35 pmRNSPrice Monitoring Extension
20th Feb 20232:05 pmRNSSecond Price Monitoring Extn
20th Feb 20232:00 pmRNSPrice Monitoring Extension
20th Feb 202311:05 amRNSSecond Price Monitoring Extn
20th Feb 202311:00 amRNSPrice Monitoring Extension
20th Feb 20239:05 amRNSSecond Price Monitoring Extn
20th Feb 20239:00 amRNSPrice Monitoring Extension
17th Feb 20234:40 pmRNSSecond Price Monitoring Extn
17th Feb 20234:35 pmRNSPrice Monitoring Extension
14th Feb 20237:00 amRNSAllotment of Shares and Total Voting Rights
10th Jan 20234:40 pmRNSSecond Price Monitoring Extn
10th Jan 20234:35 pmRNSPrice Monitoring Extension
10th Jan 20232:05 pmRNSSecond Price Monitoring Extn
10th Jan 20232:00 pmRNSPrice Monitoring Extension
9th Jan 20234:40 pmRNSSecond Price Monitoring Extn
9th Jan 20234:35 pmRNSPrice Monitoring Extension
9th Jan 20232:05 pmRNSSecond Price Monitoring Extn
9th Jan 20232:00 pmRNSPrice Monitoring Extension
3rd Jan 20231:15 pmRNSInterim Results - availability
30th Dec 20227:00 amRNSInterim Results for the Six Months Ending 30Sept22
22nd Dec 20227:00 amRNSU.S. FDA Clearance of IND Application for OK-101
21st Dec 20227:00 amRNSOKYO to Participate at Biotech Showcase
6th Dec 20227:00 amRNSOKYO files a registration statement with the SEC
1st Dec 20227:00 amRNSChange of Auditor
24th Nov 20227:00 amRNSDirector/PDMR Shareholding
21st Nov 20227:00 amRNSU.S. IND Filing on OK-101 for the Treatment of DED
20th Oct 20227:00 amRNSOKYO to participate at 2022 ThinkEquity Conference
8th Sep 20222:30 pmRNSOKYO interview on Bloomberg: RedChip Money Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.